Cancer Research Network (U19)

The summary for the Cancer Research Network (U19) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Cancer Research Network (U19): -NCI will award one grant to continue support for the NCI Cancer Research Network across Health Care Systems initiative (CRN). The CRN is expected to continue as a cooperative agreement to provide a resource that will facilitate the conduct of NCI-sponsored research on prevention, early detection, treatment, long-term care and post diagnosis monitoring in the context of health care delivery systems. To accomplish this goal, the initiative supports the development of cancer research capabilities across multiple healthcare provider organizations using integrated data systems in the context of a multi-site population-based research laboratory. -The amount of the award (total cost) is $30 million over 5 years, and includes $6 million in Fiscal Year 2006.

Federal Grant Title:	Cancer Research Network (U19)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health Education
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-CA-06-505
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.399
CFDA Descriptions:	Cancer Control
Current Application Deadline:	No deadline provided
Original Application Deadline:	Aug 17, 2006
Posted Date:	Jun 09, 2006
Creation Date:	Jun 09, 2006
Archive Date:	Sep 16, 2006
Total Program Funding:	$30,000,000
Maximum Federal Grant Award:	$6,000,000
Minimum Federal Grant Award:
Expected Number of Awards:	1
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification) For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Foreign institutions are not eligible to apply. The eligibility to apply in response to this Letter RFA is limited to current recipients of the CRN award under U19CA079689. Within the framework of the existing CRN, any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. More than one PI, or multiple PIs, may be designated on the application. Additional information on the implementation plans and policies and procedures to formally allow more than one PI on individual research awards can be found at http://grants.nih.gov/grants/multi_pi. All PIs must be registered in the eRA Commons prior to the submission of the application (see http://era.nih.gov/ElectronicReceipt/preparing.htm for instructions). The decision of whether to apply for a single PI or multiple PI grant is the responsibility of the applicant organization and should be determined by the scientific goals of the project. Applications for multiple PI grants will require additional information, as outlined in the instructions below, and the NIH review criteria for approach and investigator will be modified as indicated below. For example, a weak or inappropriate PI can have a negative effect on the review. If the multiple PIs grant option is elected, a contact PI must be named, as described in the instructions below. Multiple PIs on a project share the authority and responsibility for leading and directing the project, intellectually and logistically. Each PI is responsible and accountable to the grantee organization, or, as appropriate, to a collaborating organization, for the proper conduct of the project or program, including the submission of all required reports. Multiple PIs may request budget apportionment between the PIs (see supplementary instructions below). For multiple organizations, a subcontract or consortial arrangement must be agreed on by the participating organizations, as described in special instructions below.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Pop...; • Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34 Clinical ...; • Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01 Clinical ...; • Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials ...; • Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials ...; • Exploratory Grants for Behavioral Research in Cancer Control; • Decision Making in Cancer: Single-Event Decisions; • Small Grants for Behavioral Research in Cancer Control (R03)
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...